Blueprint Medicines Statistics
Total Valuation
OXSQ has a market cap or net worth of $179.42 million. The enterprise value is $263.58 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | Aug 15, 2025 |
Share Statistics
OXSQ has 76.03 million shares outstanding. The number of shares has increased by 17.51% in one year.
| Current Share Class | 76.03M |
| Shares Outstanding | 76.03M |
| Shares Change (YoY) | +17.51% |
| Shares Change (QoQ) | +4.66% |
| Owned by Insiders (%) | 5.80% |
| Owned by Institutions (%) | 9.11% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.06 |
| Forward PS | 4.40 |
| PB Ratio | 1.14 |
| P/TBV Ratio | 1.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.55 |
| EV / EBITDA | n/a |
| EV / EBIT | 8.23 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.23, with a Debt / Equity ratio of 0.72.
| Current Ratio | 9.23 |
| Quick Ratio | 9.23 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 4.10 |
Financial Efficiency
Return on equity (ROE) is -0.87% and return on invested capital (ROIC) is 7.31%.
| Return on Equity (ROE) | -0.87% |
| Return on Assets (ROA) | 7.08% |
| Return on Invested Capital (ROIC) | 7.31% |
| Return on Capital Employed (ROCE) | 11.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, OXSQ has paid $409,953 in taxes.
| Income Tax | 409,953 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.81% in the last 52 weeks. The beta is 0.67, so OXSQ's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -20.81% |
| 50-Day Moving Average | 2.29 |
| 200-Day Moving Average | 2.55 |
| Relative Strength Index (RSI) | 57.48 |
| Average Volume (20 Days) | 512,034 |
Short Selling Information
The latest short interest is 1.45 million, so 1.91% of the outstanding shares have been sold short.
| Short Interest | 1.45M |
| Short Previous Month | 1.54M |
| Short % of Shares Out | 1.91% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.31 |
Income Statement
In the last 12 months, OXSQ had revenue of $40.24 million and -$1.35 million in losses. Loss per share was -$0.02.
| Revenue | 40.24M |
| Gross Profit | 40.24M |
| Operating Income | 32.01M |
| Pretax Income | 9.20M |
| Net Income | -1.35M |
| EBITDA | n/a |
| EBIT | 32.01M |
| Loss Per Share | -$0.02 |
Full Income StatementBalance Sheet
The company has $29.79 million in cash and $113.95 million in debt, giving a net cash position of -$84.16 million or -$1.11 per share.
| Cash & Cash Equivalents | 29.79M |
| Total Debt | 113.95M |
| Net Cash | -84.16M |
| Net Cash Per Share | -$1.11 |
| Equity (Book Value) | 157.42M |
| Book Value Per Share | 2.06 |
| Working Capital | 28.61M |
Full Balance SheetMargins
Gross margin is 100.00%, with operating and profit margins of 79.54% and -3.35%.
| Gross Margin | 100.00% |
| Operating Margin | 79.54% |
| Pretax Margin | -2.33% |
| Profit Margin | -3.35% |
| EBITDA Margin | n/a |
| EBIT Margin | 79.54% |
| FCF Margin | n/a |
